{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:26Z","timestamp":1786112786895,"version":"build-2736575974"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:p>\n                    Potential mitochondrial biomarkers play an important role in probing COVID-19 physiopathology. We aimed to investigate the causal effects of 82 mitochondrial biomarkers on COVID-19 in a population-based public database. Based on the IEU Open genome-wide association studies database and the genome-wide association studies Catalog database, the significant single-nucleotide polymorphisms of mitochondrial and COVID-19 were extracted as instrumental variables. The inverse variance weighting (IVW) method and the Bayesian weighting method in the two-sample Mendelian randomization (MR) method were used for the main causal analysis. Sensitivity tests were performed using the MR-Egger regression test, the MR-PRESSO test for multiple residuals and outliers, the Cochran\n                    <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                    statistic, and the leave-one-out method, and directionality tests were performed using the MR-Steiger method. The protective factors of COVID-19 were determined by IVW method and Bayesian weighting method: Apoptosis-inducing factor 1, mitochondrial (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    <jats:sub>IVW<\/jats:sub>\n                    \u2005=\u20059.6\u2005\u00d7\u200510\n                    <jats:sup>\u22125<\/jats:sup>\n                    ;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    <jats:sub>BWMR<\/jats:sub>\n                    \u2005=\u20054.2\u2005\u00d7\u200510\n                    <jats:sup>\u22122<\/jats:sup>\n                    ) and risk factors: 39S ribosomal protein L33, mitochondrial (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    <jats:sub>IVW<\/jats:sub>\n                    \u2005=\u20052.8\u2005\u00d7\u200510\n                    <jats:sup>\u22123<\/jats:sup>\n                    ;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    <jats:sub>BWMR<\/jats:sub>\n                    \u2005=\u20051.9\u2005\u00d7\u200510\n                    <jats:sup>\u22123<\/jats:sup>\n                    ) and 39S ribosomal protein L52, mitochondrial (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    <jats:sub>IVW<\/jats:sub>\n                    \u2005=\u20052.0\u2005\u00d7\u200510\n                    <jats:sup>\u22122<\/jats:sup>\n                    ;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    <jats:sub>BWMR<\/jats:sub>\n                    \u2005=\u20057.3\u2005\u00d7\u200510\n                    <jats:sup>\u22123<\/jats:sup>\n                    ) and Mitochondrial ubiquitin ligase activator of NF-\u03baB-1 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    <jats:sub>IVW<\/jats:sub>\n                    \u2005=\u20052.7\u2005\u00d7\u200510\n                    <jats:sup>\u22122<\/jats:sup>\n                    ;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    <jats:sub>BWMR<\/jats:sub>\n                    \u2005=\u20054.8\u2005\u00d7\u200510\n                    <jats:sup>\u22122<\/jats:sup>\n                    ). In the sensitivity test, we did not find heterogeneity, pleiotropic and reverse causality. In this study, we identified 4 potential biomarkers of mitochondrial dysfunction associated with COVID-19, providing new insights into the realization of COVID-19 precision medicine and potential mechanisms.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048654","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:02:04Z","timestamp":1778745724000},"page":"e48654","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Potential causal role of mitochondrial biological effects in COVID-19: Evidence from Mendelian randomization study"],"prefix":"10.1097","volume":"105","author":[{"given":"Jiaxin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Second Affiliated Hospital & Institute of Emergency Medicine, Zhejiang University School of Medicine, Hangzhou, P.R. China"},{"name":"Xinjiang Institute of Technology, Aksu, P.R. China"},{"name":"School of Public Health, Zhejiang University, Hangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Second Affiliated Hospital & Institute of Emergency Medicine, Zhejiang University School of Medicine, Hangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumin","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senlin","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-an","family":"Shen","sequence":"additional","affiliation":[{"name":"School of Public Health, Zhejiang University, Hangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8547-0014","authenticated-orcid":false,"given":"Yongan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Second Affiliated Hospital & Institute of Emergency Medicine, Zhejiang University School of Medicine, Hangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41431-020-0636-6","article-title":"The COVID-19 host genetics initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.","volume":"28","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"1635043","DOI":"10.3389\/fcimb.2025.1635043","article-title":"The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.","volume":"15","author":"Dagar","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.3390\/ijms25169050","article-title":"Post-acute sequelae and mitochondrial aberration in SARS-CoV-2 infection.","volume":"25","author":"Ward","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome.","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat Immunol"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1007\/s11357-024-01165-5","article-title":"Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches.","volume":"46","author":"Molnar","year":"2024","journal-title":"Geroscience"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"108080","DOI":"10.1016\/j.isci.2023.108080","article-title":"The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity.","volume":"26","author":"Stewart","year":"2023","journal-title":"iScience"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"780768","DOI":"10.3389\/fmicb.2021.780768","article-title":"SARS-CoV-2 causes mitochondrial dysfunction and mitophagy impairment.","volume":"12","author":"Shang","year":"2021","journal-title":"Front Microbiol"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"3946320231210736","DOI":"10.1177\/03946320231210736","article-title":"Analysis of mitochondrial function in lymphocytes obtained from COVID-19 patients.","volume":"37","author":"He","year":"2023","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev-genom-090314-050016","article-title":"Mendelian randomization: new applications in the coming age of hypothesis-free causality.","volume":"16","author":"Evans","year":"2015","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/ije\/dyac149","article-title":"Tools for assessing quality and risk of bias in Mendelian randomization studies: a systematic review.","volume":"52","author":"Spiga","year":"2023","journal-title":"Int J Epidemiol"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome.","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization.","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","article-title":"METAL: fast and efficient meta-analysis of genomewide association scans.","volume":"26","author":"Willer","year":"2010","journal-title":"Bioinformatics"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"e1009922","DOI":"10.1371\/journal.pgen.1009922","article-title":"Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model.","volume":"17","author":"Lin","year":"2021","journal-title":"PLoS Genet"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ebmental-2019-300085","article-title":"Using Mendelian randomisation to assess causality in observational studies.","volume":"22","author":"Pagoni","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/sim.6835","article-title":"Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods.","volume":"35","author":"Burgess","year":"2016","journal-title":"Stat Med"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization.","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat Med"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data.","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/bioinformatics\/btz749","article-title":"Bayesian weighted Mendelian randomization for causal inference based on summary statistics.","volume":"36","author":"Zhao","year":"2020","journal-title":"Bioinformatics"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"614650","DOI":"10.3389\/fnagi.2020.614650","article-title":"Impact of COVID-19 on mitochondrial-based immunity in aging and age-related diseases.","volume":"12","author":"Ganji","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"R27-20260805","doi-asserted-by":"crossref","first-page":"102336","DOI":"10.1016\/j.ceca.2020.102336","article-title":"Role of mitochondria in liver metabolic health and diseases.","volume":"94","author":"Morio","year":"2021","journal-title":"Cell Calcium"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"101849","DOI":"10.1016\/j.mito.2024.101849","article-title":"Altered mitochondrial respiration in peripheral blood mononuclear cells of post-acute sequelae of SARS-CoV-2 infection.","volume":"75","author":"Dirajlal-Fargo","year":"2024","journal-title":"Mitochondrion"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1186\/s12967-023-04787-z","article-title":"Landscape of molecular crosstalk between SARS-CoV-2 infection and cardiovascular diseases: emphasis on mitochondrial dysfunction and immune-inflammation.","volume":"21","author":"Dai","year":"2023","journal-title":"J Transl Med"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12864-024-10194-5","article-title":"Decoding HiPSC-CM\u2019s response to SARS-CoV-2: mapping the molecular landscape of cardiac injury.","volume":"25","author":"Chen","year":"2024","journal-title":"BMC Genomics"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"C57","DOI":"10.1152\/ajpcell.00426.2020","article-title":"Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19.","volume":"320","author":"Ajaz","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.3390\/ijms25094941","article-title":"Mechanisms of pulmonary vasculopathy in acute and long-term COVID-19: a review.","volume":"25","author":"Riou","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R33-20260805","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.007","article-title":"Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/glycolysis-dependent axis.","volume":"32","author":"Codo","year":"2020","journal-title":"Cell Metab"},{"key":"R34-20260805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2020.06.008","article-title":"Mitochondria and microbiota dysfunction in COVID-19 pathogenesis.","volume":"54","author":"Saleh","year":"2020","journal-title":"Mitochondrion"},{"key":"R35-20260805","doi-asserted-by":"crossref","first-page":"e2321972121","DOI":"10.1073\/pnas.2321972121","article-title":"Mitochondrial antioxidants abate SARS-COV-2 pathology in mice.","volume":"121","author":"Guarnieri","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R36-20260805","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/sj.onc.1207279","article-title":"AIF and cyclophilin a cooperate in apoptosis-associated chromatinolysis.","volume":"23","author":"Cand\u00e9","year":"2004","journal-title":"Oncogene"},{"key":"R37-20260805","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/cdd.2009.211","article-title":"A brain-specific isoform of mitochondrial apoptosis-inducing factor: AIF2.","volume":"17","author":"Hangen","year":"2010","journal-title":"Cell Death Differ"},{"key":"R38-20260805","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/emboj.2010.43","article-title":"AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX.","volume":"29","author":"Artus","year":"2010","journal-title":"EMBO J"},{"key":"R39-20260805","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41418-022-00928-x","article-title":"SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK.","volume":"29","author":"Yang","year":"2022","journal-title":"Cell Death Differ"},{"key":"R40-20260805","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCULATIONAHA.120.047915","article-title":"Differentiating COVID-19 pneumonia from acute respiratory distress syndrome and high altitude pulmonary edema: therapeutic implications.","volume":"142","author":"Archer","year":"2020","journal-title":"Circulation"},{"key":"R41-20260805","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2014.04.040","article-title":"Porcine epidemic diarrhea virus induces caspase-independent apoptosis through activation of mitochondrial apoptosis-inducing factor.","volume":"460-461","author":"Kim","year":"2014","journal-title":"Virology"},{"key":"R42-20260805","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappaB.","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev"},{"key":"R43-20260805","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.humimm.2022.06.002","article-title":"Genetic variants in the NF-\u03baB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients.","volume":"83","author":"Camblor","year":"2022","journal-title":"Hum Immunol"},{"key":"R44-20260805","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41440-023-01460-2","article-title":"The role of SARS-CoV-2-mediated NF-\u03baB activation in COVID-19 patients.","volume":"47","author":"Zhou","year":"2024","journal-title":"Hypertens Res"},{"key":"R45-20260805","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1681\/ASN.2020050589","article-title":"Remdesivir in patients with acute or chronic kidney disease and COVID-19.","volume":"31","author":"Adamsick","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"R46-20260805","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2012.02.033","article-title":"Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy.","volume":"322","author":"Ling","year":"2012","journal-title":"Cancer Lett"},{"key":"R47-20260805","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1038\/s41467-021-24818-x","article-title":"A distinct assembly pathway of the human 39S late pre-mitoribosome.","volume":"12","author":"Cheng","year":"2021","journal-title":"Nat Commun"},{"key":"R48-20260805","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41392-021-00726-w","article-title":"HIF-1\u03b1 promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19.","volume":"6","author":"Tian","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R49-20260805","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/onc.2017.314","article-title":"MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression.","volume":"37","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"R50-20260805","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.7150\/thno.57804","article-title":"HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia.","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"R51-20260805","doi-asserted-by":"crossref","first-page":"109091","DOI":"10.1016\/j.celrep.2021.109091","article-title":"METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.","volume":"35","author":"Li","year":"2021","journal-title":"Cell Rep"},{"key":"R52-20260805","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1038\/s41467-024-46366-w","article-title":"NDUFS4 regulates cristae remodeling in diabetic kidney disease.","volume":"15","author":"Mise","year":"2024","journal-title":"Nat Commun"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:01:34Z","timestamp":1785945694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":52,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048654","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2025-08-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}